AUSPEX PHARMACEUTICAL INC has a total of 24 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are EGIS GYOGYSZERGYAR NYILVANOSAN, COLUCID PHARMACEUTICALS INC and YANGTZE RIVER PHARM GROUP CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | United States | 4 | |
#3 | China | 3 | |
#4 | Australia | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Gant Thomas G | 20 |
#2 | Sarshar Sepehr | 9 |
#3 | Shahbaz Manouchehr | 7 |
#4 | Zhang Chengzhi | 6 |
#5 | Shahbaz Manoucherhr | 6 |
#6 | Hong Borcherng | 2 |
#7 | Chavan Vishal P | 1 |
#8 | Manoucherhr Shahbaz | 1 |
#9 | Nagarajan Arumugam | 1 |
#10 | Tse Bruno | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011123524A2 | Macrolide inhibitors of mtor | |
WO2010068720A2 | Podophyllotoxin inhibitors of topoisomerase ii | |
WO2010077730A2 | Indanone inhibitors of acetylcholinesterase | |
WO2010065746A2 | Piperazine modulators of nk-1 receptors | |
WO2010048358A2 | Ethoxyphenylmethyl inhibitors of sglt2 | |
US2010069399A1 | Arylpiperazine modulators of d2 receptors, 5-ht1a receptors, and/or 5-ht2a receptors |